Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Daclatasvir formerly BMS-790052
.
Show all posts
Showing posts with label
Daclatasvir formerly BMS-790052
.
Show all posts
Monday, April 11, 2016
EC approves expanded use of Daklinza (daclatasvir) for patients with chronic HCV and HIV co-infection
›
Daclatasvir formerly BMS-790052 , trade name Daklinza ) is a drug for the treatment of hepatitis C (HCV). It was developed by Bri...
›
Home
View web version
